UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001738 |
|---|---|
| Receipt number | R000002091 |
| Scientific Title | Phase II study of gefitinib therapy inserted by chemotherapy as first line treatment for advanced non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutation |
| Date of disclosure of the study information | 2009/03/01 |
| Last modified on | 2013/09/05 15:16:46 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/02/27 10:57:21 | ||
| 2 | Update | 2012/03/27 17:45:22 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 3 | Update | 2012/03/27 17:46:04 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2013/09/05 15:13:25 | Email |
|
| 5 | Update | 2013/09/05 15:16:46 | Recruitment status Date analysis concluded Publication of results |
